Literature DB >> 19149681

Crystallization and preliminary X-ray crystallographic analysis of human plasma platelet activating factor acetylhydrolase.

Uttamkumar Samanta1, Cheryl Wilder, Brian J Bahnson.   

Abstract

The plasma form of the human enzyme platelet activating factor acetylhydrolase (PAF-AH) has been crystallized, and X-ray diffraction data were collected at a synchrotron source to a resolution of 1.47 A. The crystals belong to space group C2, with unit cell parameters of a = 116.18, b = 83.06, c = 96.71 A, and beta= 115.09 degrees and two molecules in the asymmetric unit. PAF-AH functions as a general anti-inflammatory scavenger by reducing the levels of the signaling molecule PAF. Additionally, the LDL bound enzyme has been linked to atherosclerosis due to its hydrolytic activities of pro-inflammatory agents, such as sn-2 oxidatively fragmented phospholipids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149681      PMCID: PMC3220998          DOI: 10.2174/092986609787049321

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  16 in total

Review 1.  The phospholipase A2 superfamily and its group numbering system.

Authors:  Ralph H Schaloske; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2006-08-03

2.  Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution.

Authors:  Y Wei; L Swenson; C Castro; U Derewenda; W Minor; H Arai; J Aoki; K Inoue; L Servin-Gonzalez; Z S Derewenda
Journal:  Structure       Date:  1998-04-15       Impact factor: 5.006

3.  Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.

Authors:  J H Min; C Wilder; J Aoki; H Arai; K Inoue; L Paul; M H Gelb
Journal:  Biochemistry       Date:  2001-04-17       Impact factor: 3.162

Review 4.  Platelet-activating factor acetylhydrolase.

Authors:  Hiroyuki Arai
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

5.  Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.

Authors:  K E Stremler; D M Stafforini; S M Prescott; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

6.  Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer.

Authors:  Y S Ho; L Swenson; U Derewenda; L Serre; Y Wei; Z Dauter; M Hattori; T Adachi; J Aoki; H Arai; K Inoue; Z S Derewenda
Journal:  Nature       Date:  1997-01-02       Impact factor: 49.962

Review 7.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad.

Authors:  L W Tjoelker; C Eberhardt; J Unger; H L Trong; G A Zimmerman; T M McIntyre; D M Stafforini; S M Prescott; P W Gray
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

9.  Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

Authors:  D M Stafforini; T M McIntyre; M E Carter; S M Prescott
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

10.  Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans.

Authors:  Takao Inoue; Asako Sugimoto; Yuka Suzuki; Masayuki Yamamoto; Masafumi Tsujimoto; Keizo Inoue; Junken Aoki; Hiroyuki Arai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

View more
  2 in total

Review 1.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

2.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.